vaccines, synthetic

Preferred Label : vaccines, synthetic;

MeSH definition : Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.;

MeSH synonym : immunogens, synthetic; synthetic vaccines; synthetic immunogens; Synthetic Vaccine; Vaccine, Synthetic;

MeSH Hyperonym : antigens, synthetic; Synthetic Antigens; Synthetic Antigen; Antigen, Synthetic;

MeSH hyponym : molecular vaccines; vaccines, recombinant; semisynthetic vaccines; Vaccines, Semisynthetic; Vaccines, Molecular; Vaccines, Chemical; Chemical Vaccines; Recombinant Vaccines; Semisynthetic Vaccine; Vaccine, Semisynthetic; Molecular Vaccine; Vaccine, Molecular; Chemical Vaccine; Vaccine, Chemical; Recombinant Vaccine; Vaccine, Recombinant;

MeSH annotation : IM general only; coord NIM with specific vaccine (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Recombinant vaccines;

Is substance : O;

Details

Origin ID

D014614;

UMLS CUI

C0042213;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
- virology [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Recombinant Vaccinia-CEA [NCIt concept]
- Recombinant Vaccinia-Prostate Specific Antigen [NCIt concept]
- recombinant protein subunit vaccine [COVID-19 Thesaurus concept]
Indexing information
- 3,6-di-O-methyl-beta-glucopyranosyl-(1-4)-2,3-di-O-methyl-alpha-rhamnopyranose [MeSH Supplementary Concept]
- COMVAX [MeSH Supplementary Concept]
- CpG ODN-OVA [MeSH Supplementary Concept]
- Engerix-B [MeSH Supplementary Concept]
- FANG vaccine [MeSH Supplementary Concept]
- Fendrix [MeSH Supplementary Concept]
- GapC protein, streptococcus [MeSH Supplementary Concept]
- HIV-1 IIIB gp120 subunit vaccine [MeSH Supplementary Concept]
- HibTITER protein, haemophilus influenzae [MeSH Supplementary Concept]
- Lmdd-MPFG vaccine [MeSH Supplementary Concept]
- MSP3 protein, plasmodium falciparum (181-276) [MeSH Supplementary Concept]
- MVA 85A [MeSH Supplementary Concept]
- NP protein, influenza A virus [MeSH Supplementary Concept]
- Omp31 protein, brucella melitensis (48-74) [MeSH Supplementary Concept]
- PROSTVAC [MeSH Supplementary Concept]
- PfCSP DNA vaccine [MeSH Supplementary Concept]
- Pre-S protein, duck hepatitis B virus [MeSH Supplementary Concept]
- Pre-S vaccine [MeSH Supplementary Concept]
- R 32NS1(81) [MeSH Supplementary Concept]
- SNC-rCTB vaccine [MeSH Supplementary Concept]
- SPf66 protein, plasmodium [MeSH Supplementary Concept]
- Sj22.6-26GST vaccine [MeSH Supplementary Concept]
- TA-Gw vaccine [MeSH Supplementary Concept]
- Theradigm-HBV [MeSH Supplementary Concept]
- VAX102 vaccine [MeSH Supplementary Concept]
- VGX-3100 [MeSH Supplementary Concept]
- VaxSyn HIV-1 (gp160) vaccine [MeSH Supplementary Concept]
- glycoprotein gp70, feline leukemia virus [MeSH Supplementary Concept]
- group B streptococcal type III capsular polysaccharide-tetanus toxoid vaccine [MeSH Supplementary Concept]
- group B streptococcal type ia capsular polysaccharide-tetanus toxoid vaccine [MeSH Supplementary Concept]
- group B streptococcal type ib capsular polysaccharide-tetanus toxoid vaccine [MeSH Supplementary Concept]
- octopus construct 115-131 [MeSH Supplementary Concept]
- ro 40-2361 [MeSH Supplementary Concept]
- salk HIV immunogen [MeSH Supplementary Concept]
- streptococcal polysaccharide type II-tetanus toxoid conjugate vaccine [MeSH Supplementary Concept]
- transmission-Blocking vaccine based on Pfs25 [MeSH Supplementary Concept]
Record concept(s)
- antigens, synthetic [MeSH concept]
- molecular vaccines [MeSH concept]
- semisynthetic vaccines [MeSH concept]
- vaccines, recombinant [MeSH concept]
- vaccines, synthetic [MeSH concept]
Related MeSH Supplementary Concept(s)
- (NANP)19-5.1 [MeSH Supplementary Concept]
- (T1BT)4-P3C polyoxime vaccine [MeSH Supplementary Concept]
- ACM-001 COVID-19 vaccine [MeSH Supplementary Concept]
- ALVAC-CEA vaccine [MeSH Supplementary Concept]
- ALVAC-HIV vCP205 vaccine [MeSH Supplementary Concept]
- D protein, influenza A (A-PR-8-34-derived recombinant protein) [MeSH Supplementary Concept]
- EpiVacCorona vaccine [MeSH Supplementary Concept]
- Euvax-B [MeSH Supplementary Concept]
- GI 5005 [MeSH Supplementary Concept]
- Gam-COVID-Vac vaccine [MeSH Supplementary Concept]
- PfCP2.9 vaccine [MeSH Supplementary Concept]
- RTS,S-AS01 vaccine [MeSH Supplementary Concept]
- SCTV01C vaccine [MeSH Supplementary Concept]
- VB10.COV-2 vaccine [MeSH Supplementary Concept]
- VXA-CoV2-1.1-S vaccine [MeSH Supplementary Concept]
- adenovirus 5, rabies glycoprotein recombinant vaccine [MeSH Supplementary Concept]
- hecolin [MeSH Supplementary Concept]
- mRNA Vaccine [MeSH Supplementary Concept]
- pH3IH1 RNA vaccine [MeSH Supplementary Concept]
- rAd40 [MeSH Supplementary Concept]
- rF-B7.1 vaccine [MeSH Supplementary Concept]
- rF-TRICOM vaccine [MeSH Supplementary Concept]
- rV-Tricom [MeSH Supplementary Concept]
- recombivax HB [MeSH Supplementary Concept]
- vaccinia-CEA vaccine [MeSH Supplementary Concept]
- versamune-CoV-2FC vaccine [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients